Nectar Lifesciences LtdPharmaceuticalsINE023H01027Consolidated₹10.93-0.05 (-0.46%)Jun-26
Valuation
Market Cap₹212.33 Cr
TTM PE-3.17x
Forward PE-2.38x
PEG0.09
Book Value₹29.97
P/B0.36x
TTM EPS₹-3.45
Fwd EPS₹-4.59
TTM Revenue₹5.01 Cr
TTM PAT₹-245.06 Cr
TTM EBITDA₹-119.48 Cr
TTM EBIT₹-119.87 Cr
Last Qtr PAT₹-15.40 Cr
Last Qtr EBITDA₹-27.70 Cr
Last Qtr EBIT₹-27.81 Cr
Profitability
ROE-42.08%
ROCE-3.33%
TTM NPM-4891.42%
TTM EBITDA %-2384.83%
Curr OPM-458.33%
Last OPM-896.04%
Curr NPM—
Last NPM—
Curr EPS₹-0.79
Last EPS₹-3.38
Balance sheet
Equity₹19.43 Cr
Reserve₹562.87 Cr
Total Debt₹0.00 Cr
D/E0.00x
Interest %-1.04%
Curr Interest₹0.16 Cr
Price / range
Close₹10.93
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D-0.46%
1W-4.96%
1M+4.39%
3M-4.46%
6M-0.09%
1Y-31.86%
2Y-74.12%
3Y-56.00%
5Y-61.78%
Diwali-46.60%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits